Advanced search
Publication Cover
Acta Oncologica Volume 46, 2007 - Issue 7
Journal homepage
1,371
Views
48
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Clinical outcome in patients with prostate cancer treated with external beam radiotherapy and high dose-rate iridium 192 brachytherapy boost: A 6-year follow-up

Karl Mikael Kälkner Department of Oncology-Pathology, Radiumhemmet, Karolinska University Hospital and Institute, Stockholm, SwedenCorrespondence[email protected]
,
Thomas Wahlgren Department of Oncology-Pathology, Radiumhemmet, Karolinska University Hospital and Institute, Stockholm, Sweden
,
Marianne Ryberg Department of Oncology-Pathology, Radiumhemmet, Karolinska University Hospital and Institute, Stockholm, Sweden
,
Gabriella Cohn-Cedermark Department of Oncology-Pathology, Radiumhemmet, Karolinska University Hospital and Institute, Stockholm, Sweden
,
Enrique Castellanos Department of Oncology-Pathology, Radiumhemmet, Karolinska University Hospital and Institute, Stockholm, Sweden
,
Rolf Zimmerman Department of Oncology-Pathology, Södersjukhuset, Karolinska University Hospital and Institute, Stockholm, Sweden
,
Josef Nilsson Department of Medical Physics, Karolinska University Hospital and Institute, Stockholm, Sweden
,
Marie Lundell Department of Medical Physics, Karolinska University Hospital and Institute, Stockholm, Sweden
,
Jack Fowler Department of Human Oncology, University of Wisconsin Medical School, Madison, USA
,
Seymour Levitt Department of Oncology-Pathology, Radiumhemmet, Karolinska University Hospital and Institute, Stockholm, Sweden; Department of Therapeutic Radiology, University of Minnesota, Minneapolis, MN, USA
,
Magnus Hellström Department of Urology, Karolinska University Hospital and Institute, Stockholm, Sweden
&
Sten Nilsson Department of Oncology-Pathology, Radiumhemmet, Karolinska University Hospital and Institute, Stockholm, Sweden
 show all
Pages 909-917 | Received 24 Jun 2006, Published online: 08 Jul 2009

Citations (48)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Marie Hjälm-Eriksson, Anders Ullén, Sten Nilsson, Hemming Johansson, Josef Nilsson, Enrique Castellanos & Yvonne Brandberg. (2022) High levels of health-related quality of life five years after curative treatment of prostate cancer with HDR-brachytherapy and external beam radiation. Acta Oncologica 61:10, pages 1179-1185.
Read now
Marie Hjälm-Eriksson, Sten Nilsson, Yvonne Brandberg, Hemming Johansson, Bo Lennernäs, Göran Lundell, Enrique Castellanos & Anders Ullén. (2021) High rate of local control and cure at 10 years after treatment of prostate cancer with external beam radiotherapy and high-dose-rate brachytherapy: a single centre experience. Acta Oncologica 60:10, pages 1301-1307.
Read now
Marie Hjälm-Eriksson, Anders Ullén, Hemming Johansson, Seymoure Levitt, Sten Nilsson & Karl-Mikael Kälkner. (2017) Comorbidity as a predictor of overall survival in prostate cancer patients treated with external beam radiotherapy combined with HDR brachytherapy boosts. Acta Oncologica 56:1, pages 21-26.
Read now
Nicholas G Zaorsky, Laura A Doyle, Mark D Hurwitz, Adam P Dicker & Robert B Den. (2014) Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?. Expert Review of Anticancer Therapy 14:1, pages 39-50.
Read now
Nicholas G Zaorsky, Robert B Den, Laura A Doyle, Adam P Dicker & Mark D Hurwitz. (2013) Combining theoretical potential and advanced technology in high-dose rate brachytherapy boost therapy for prostate cancer. Expert Review of Medical Devices 10:6, pages 751-763.
Read now
Ulrika Harmenberg, Freddie C. Hamdy, Anders Widmark, Bo Lennernäs & Sten Nilsson. (2011) Curative radiation therapy in prostate cancer. Acta Oncologica 50:sup1, pages 98-103.
Read now
Christina Skourou, P. Jack Hoopes, Summer L. Gibbs-Strauss, David J. Gladstone, Rendall Strawbridge & Keith D. Paulsen. (2009) High dose rate radiation treatment of experimental intramuscular prostate carcinoma. International Journal of Radiation Biology 85:4, pages 330-337.
Read now

Articles from other publishers (41)

Kevin Martell & Marisa A. Kollmeier. (2021) Complications and side effects of high-dose-rate prostate brachytherapy. Brachytherapy 20:5, pages 966-975.
Crossref
Cinzia Imberti & Peter J. Sadler. 2020. Medicinal Chemistry. Medicinal Chemistry 3 56 .
Benjamin W. Fischer-Valuck, Hiram A. Gay, Sagar Patel, Brian C. Baumann & Jeff M. Michalski. (2019) A Brief Review of Low-Dose Rate (LDR) and High-Dose Rate (HDR) Brachytherapy Boost for High-Risk Prostate. Frontiers in Oncology 9.
Crossref
Ashraf Talaat Youssef. (2017) Local Staging of Prostate Cancer Using Three Dimensional (3D) Transrectal Ultrasound Assisted with Power Doppler Capability. Journal of Analytical Oncology 6:1.
Crossref
Nicholas G. Zaorsky, Brian J. Davis, Paul L. Nguyen, Timothy N. Showalter, Peter J. Hoskin, Yasuo Yoshioka, Gerard C. Morton & Eric M. Horwitz. (2017) The evolution of brachytherapy for prostate cancer. Nature Reviews Urology 14:7, pages 415-439.
Crossref
J. Cordes, J. Broschk, M. Sommerauer, D. Jocham, A. S. Merseburger, C. Melchert & G. Kovács. (2016) Fokale Dosiseskalation in der Therapie des ProstatakarzinomsFocal dose escalation in the treatment of prostate cancer. Der Urologe 56:2, pages 157-166.
Crossref
Nicholas G. Zaorsky, Talha Shaikh, Colin T. Murphy, Mark A. Hallman, Shelly B. Hayes, Mark L. Sobczak & Eric M. Horwitz. (2016) Comparison of outcomes and toxicities among radiation therapy treatment options for prostate cancer. Cancer Treatment Reviews 48, pages 50-60.
Crossref
Alicia Olarte, Mauricio Cambeiro, Marta Moreno-Jiménez, Leire Arbea, José Luis Pérez-Gracia, Ignacio Gil-Bazo, Ignacio Pascual, Javier Aristu & Rafael Martínez-Monge. (2016) Dose escalation with external beam radiation therapy and high-dose-rate brachytherapy combined with long-term androgen deprivation therapy in high and very high risk prostate cancer: Comparison of two consecutive high-dose-rate schemes. Brachytherapy 15:2, pages 127-135.
Crossref
Nicholas G. Zaorsky & Eric M. Horwitz. 2016. Prostate Cancer. Prostate Cancer 399 411 .
H. Ishiyama, T. Satoh, M. Kitano, K.-i. Tabata, S. Komori, M. Ikeda, I. Soda, S. Kurosaka, A. Sekiguchi, M. Kimura, S. Kawakami, M. Iwamura & K. Hayakawa. (2013) High-dose-rate brachytherapy and hypofractionated external beam radiotherapy combined with long-term hormonal therapy for high-risk and very high-risk prostate cancer: outcomes after 5-year follow-up. Journal of Radiation Research 55:3, pages 509-517.
Crossref
Nicholas G. Zaorsky, Laura A. Doyle, Kosj Yamoah, Jocelyn A. Andrel, Edouard J. Trabulsi, Mark D. Hurwitz, Adam P. Dicker & Robert B. Den. (2014) High dose rate brachytherapy boost for prostate cancer: A systematic review. Cancer Treatment Reviews 40:3, pages 414-425.
Crossref
J. Conibear & P.J. Hoskin. 2014. Prostate Cancer. Prostate Cancer 170 190 .
Nicholas G. Zaorsky, Amy S. Harrison, Edouard J. Trabulsi, Leonard G. Gomella, Timothy N. Showalter, Mark D. Hurwitz, Adam P. Dicker & Robert B. Den. (2013) Evolution of advanced technologies in prostate cancer radiotherapy. Nature Reviews Urology 10:10, pages 565-579.
Crossref
Peter J. Hoskin, Alessandro Colombo, Ann Henry, Peter Niehoff, Taran Paulsen Hellebust, Frank-Andre Siebert & Gyorgy Kovacs. (2013) GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: An update. Radiotherapy and Oncology 107:3, pages 325-332.
Crossref
B. R. Pieters & E. D. Geijsen. 2013. Interstitial Prostate Brachytherapy. Interstitial Prostate Brachytherapy 203 206 .
Mutahir A. Tunio, Altaf Hashmi, Amjad Sattar, Rehan Mohsin, Shoukat Ali & Amir Maqbool. (2012) Conformal radiotherapy plus high dose rate brachytherapy prostate boost in patients with intermediate and high risk prostate cancer: our experience in Asian males. Journal of Radiotherapy in Practice 11:4, pages 257-270.
Crossref
A Challapalli, E Jones, C Harvey, G O Hellawell & S A Mangar. (2012) High dose rate prostate brachytherapy: an overview of the rationale, experience and emerging applications in the treatment of prostate cancer. The British Journal of Radiology 85:special_issue_1, pages S18-S27.
Crossref
M. Ghilezan. (2012) Role of high dose rate brachytherapy in the treatment of prostate cancer. Cancer/Radiothérapie 16:5-6, pages 418-422.
Crossref
Michael A. Myers, Michael P. Hagan, Dorin Todor, Lynn Gilbert, Nitai Mukhopadhyay, Jessica Randolf, Jeffrey Heimiller & Mitchell S. Anscher. (2012) Phase I/II trial of single-fraction high-dose-rate brachytherapy–boosted hypofractionated intensity-modulated radiation therapy for localized adenocarcinoma of the prostate. Brachytherapy 11:4, pages 292-298.
Crossref
S. M. Oliveira, N. J. Teixeira & L. Fernandes. (2012) What do we know about the α/β for prostate cancer?. Medical Physics 39:6Part1, pages 3189-3201.
Crossref
Peter J. Hoskin, Ana M. Rojas, Peter J. Bownes, Gerry J. Lowe, Peter J. Ostler & Linda Bryant. (2012) Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer. Radiotherapy and Oncology 103:2, pages 217-222.
Crossref
Fabio L. Cury, Marie Duclos, Armen Aprikian, Horacio Patrocinio, Wassim Kassouf, George Shenouda, Sergio Faria, Marc David & Luis Souhami. (2012) Single-Fraction High-Dose-Rate Brachytherapy and Hypofractionated External Beam Radiation Therapy in the Treatment of Intermediate-Risk Prostate Cancer – Long Term Results. International Journal of Radiation Oncology*Biology*Physics 82:4, pages 1417-1423.
Crossref
Yoshiya Yamada, Leland Rogers, D. Jeffrey Demanes, Gerard Morton, Bradley R. Prestidge, Jean Pouliot, Gil'ad N. Cohen, Marco Zaider, Mihai Ghilezan & I-Chow Hsu. (2012) American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy. Brachytherapy 11:1, pages 20-32.
Crossref
Michel Ghilezan & Alvaro A. Martinez. 2012. Clinical Radiation Oncology. Clinical Radiation Oncology 259 286 .
Alberto Bossi, Rodolfe Verstraet, Lucie Calmels & Pierre Blanchard. 2012. Management of Prostate Cancer. Management of Prostate Cancer 129 142 .
Bradley R. Pieters, Elisa Rezaie, Elisabeth D. Geijsen, Kees Koedooder, Johan N.B. van der Grient, Leo E.C.M. Blank, Theo M. de Reijke & Caro C.E. Koning. (2011) Development of Late Toxicity and International Prostate Symptom Score Resolution After External-Beam Radiotherapy Combined With Pulsed Dose Rate Brachytherapy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics 81:3, pages 758-764.
Crossref
Mutahir Tunio, Altaf Hashmi, Mansoor Rafi, Rehan Mohsin & Asad Zameer. (2010) Influence of catheters on predicted tumour control probability and severity of acute genitourinary toxicity during high-dose-rate brachytherapy prostate boost. Journal of Radiotherapy in Practice 10:3, pages 173-180.
Crossref
Péter Ágoston, Tibor Major, Georgina Fröhlich, Zoltán Szabó, József Lövey, János Fodor, Miklós Kásler & Csaba Polgár. (2011) Moderate dose escalation with single-fraction high-dose-rate brachytherapy boost for clinically localized intermediate- and high-risk prostate cancer: 5-year outcome of the first 100 consecutively treated patients. Brachytherapy 10:5, pages 376-384.
Crossref
Bradley R. Pieters, Elisabeth D. Geijsen, Kees Koedooder, Leo E.C.M. Blank, Elisa Rezaie, Johan N.B. van der Grient, Theo M. de Reijke & Caro C.E. Koning. (2011) Treatment Results of PDR Brachytherapy Combined With External Beam Radiotherapy in 106 Patients With Intermediate- to High-Risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics 79:4, pages 1037-1042.
Crossref
Jeff M. Michalski & Thomas Wiegel. 2012. Technical Basis of Radiation Therapy. Technical Basis of Radiation Therapy 949 1025 .
Alan J. Katz, Michael Santoro, Richard Ashley, Ferdinand Diblasio & Matthew Witten. (2010) Stereotactic Body Radiotherapy as Boost for Organ-confined Prostate Cancer. Technology in Cancer Research & Treatment 9:6, pages 575-582.
Crossref
Israel Deutsch, Michael J. Zelefsky, Zhigang Zhang, Qianxing Mo, Marco Zaider, Gil’ad Cohen, Oren Cahlon & Yoshiya Yamada. (2010) Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT. Brachytherapy 9:4, pages 313-318.
Crossref
Min Zhang, Michael Siedow, Gregory Saia & Arnab Chakravarti. (2010) Inhibition of p21‐activated kinase 6 (PAK6) increases radiosensitivity of prostate cancer cells. The Prostate 70:8, pages 807-816.
Crossref
Jeanette Valero, Mauricio Cambeiro, Carlos Galán, Mercedes Teijeira, Pilar Romero, Javier Zudaire, Marta Moreno, Raquel Ciérvide, José Javier Aristu & Rafael Martínez-Monge. (2010) Phase II Trial of Radiation Dose Escalation With Conformal External Beam Radiotherapy and High-Dose-Rate Brachytherapy Combined With Long-Term Androgen Suppression in Unfavorable Prostate Cancer: Feasibility Report. International Journal of Radiation Oncology*Biology*Physics 76:2, pages 386-392.
Crossref
Daniel R. Zwahlen, Nick Andrianopoulos, Bronwyn Matheson, Gillian M. Duchesne & Jeremy L. Millar. (2010) High-dose-rate brachytherapy in combination with conformal external beam radiotherapy in the treatment of prostate cancer. Brachytherapy 9:1, pages 27-35.
Crossref
Bradley R. Pieters, Djuna Z. de Back, Caro C.E. Koning & Aeilko H. Zwinderman. (2009) Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: A systematic review. Radiotherapy and Oncology 93:2, pages 168-173.
Crossref
Charlotte L. Foley & Mark R. Feneley. (2009) The clinical significance and therapeutic implications of extraprostatic invasion. Surgical Oncology 18:3, pages 203-212.
Crossref
Yoshimi Tamura, Tomoko Koya, Takahiro Morita, Yutaka Kubota, Osamu Takahashi, Isao Fujiduka, Kazuto Ito & Kazuhiro Suzuki. (2009) CLINICAL RESEARCH OF PROSTATE CANCER DETECTED IN TONE CENTRAL HOSPITAL-COMPARISON OF SURVIVAL RATES BETWEEN PATIENTS DIAGNOSED WITH PROSTATE CANCER IN AND OUTSIDE SCREENING SYSTEM-. The Japanese Journal of Urology 100:4, pages 525-533.
Crossref
Ira Skvortsova, Sergej Skvortsov, Taras Stasyk, Uma Raju, Bela-Andre Popper, Bernhard Schiestl, Elisabeth von Guggenberg, Andreas Neher, Guenther K. Bonn, Lukas A. Huber & Peter Lukas. (2008) Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells. PROTEOMICS 8:21, pages 4521-4533.
Crossref
Jack F. Fowler. (2008) Isn't It Reasonable to Ask for Fraction Numbers?. International Journal of Radiation Oncology*Biology*Physics 72:2, pages 313-314.
Crossref
Josef Nilsson, Karl Mikael Kälkner, Lars Berg, Seymour Levitt, Carina Holmberg, Sten Nilsson & Marie Lundell. (2008) Is the Use of a Surrogate Urethra an Option in Prostate High-Dose-Rate Brachytherapy?. International Journal of Radiation Oncology*Biology*Physics 71:1, pages 36-40.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.